Frontlight ResearchEarly access
Trial site
Markhot Ferenc Oktatokorhaz es Rendelointezet
- 2running trials
- 5closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Chronic lymphocytic leukaemia1 trial
- Crohn's disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Glaucoma1 trial
- Hodgkin lymphoma1 trial
- Liver cirrhosis1 trial
- Macular degeneration1 trial
- Multiple myeloma1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 37 trials
- Status
- Completed5 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Grifols Therapeutics LLC2 trials
- Eli Lilly and Company1 trial
- Incyte Corporation1 trial
- Omikron Italia S.r.l.1 trial
- Shanghai Henlius Biotech1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia1 recruiting
- Hodgkin lymphoma1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Active, not recruiting
Completed
A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026